Rare Hereditary Cardiac Amyloidosis Treated With SGLT2 Inhibitor
Background Rare hereditary cardiac amyloidosis (CA) may mimic transthyretin or light-chain cardiomyopathy, and reports for effective therapy in these entities are limited. Case Summary A 61-year-old man presented with progressive heart failure (NYHA functional class III). Medical history included bilateral carpal tunne...